Get more replies from employers
Send a job-specific resume in minutes.
Roivant Sciences invites recent graduates to join its two-year Rotational Analyst Program in New York, offering four six-month rotations across diverse teams, including the Roivant portfolio of Vants. Analysts own projects from day one and develop into future leaders with exposure to senior executives.
Graduates pursue full-time roles within Roivant or its Vants after completion. The program emphasizes intellectual curiosity, collaboration, and a fast-paced healthcare environment.
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize medicines and technologies. Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 Vants; 12 consecutive positive Phase 3 trials; 8 FDA approvals; 5 successful IPOs; >$6B in capital raised; >$10B in global pharma partnerships and proceeds; and continued pipeline expansion across various modalities and therapeutic areas through in-licensing and acquisition of novel product candidates and technology platforms. In addition to a robust clinical stage pipeline, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize medicines and technologies. Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 Vants; 12 consecutive positive Phase 3 trials; 8 FDA approvals; 5 successful IPOs; >$6B in capital raised; >$10B in global pharma partnerships and proceeds; and continued pipeline expansion across various modalities and therapeutic areas through in-licensing and acquisition of novel product candidates and technology platforms. In addition to a robust clinical stage pipeline, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. We embrace diversity across all dimensions and levels of the organization, and we strive to ensure every employee is supported in reaching their full potential. We hire motivated people with diverse backgrounds, identities, experiences and skillsets. We are committed to fostering an inclusive culture where all employees feel valued, respected and empowered to create value for patients. To learn more about our story and company culture, please visit us at https://roivant.com/
Our two-year Rotational Analyst Program begins in July 2027. It offers recent college graduates the opportunity to complete four (4) six-month rotations across different teams and functions, including our portfolio of Vants. The aim of this program is to attract and develop future leaders across the Roivant family by accelerating the development of talent. From day one, analysts will own projects and have opportunities to make a meaningful impact. Now in its seventh year, Rotational Analysts have taken on demanding projects across a wide range of functions at Roivant and the Vants.
Each year, graduates of our Rotational Analyst Program pursue exciting opportunities as full-time employees at Roivant or our Vants. Beyond the Roivant portfolio, RAs have gone on to pursue higher education at top universities.
Roivant is a Fast Company Best Workplace for Innovators, with the Rotational Analyst Program recognized as a standout among Science and Technology firms.
We believe our employees are our most important asset. Our goal is to identify top talent with potential to develop into future leaders across our business. We prioritize intellect and entrepreneurial verve. We offer a fast-paced environment that values work ethic, analytical rigor, collaboration, and creative thinking. At Roivant, we will give you the resources and freedom to tackle some of the most important and challenging problems in healthcare. If you find that exciting, we want to work with you. Below, we’ve listed some preferred characteristics and requirements for our incoming Rotational Analysts.
The expected base salary for the role is $100,000 per year at the commencement of employment.
Base salary if hired is only part of the total compensation package, which, depending on the position, may also include other components such as discretionary bonuses, equity, and Company-sponsored benefit programs.
This position is at-will and Roivant reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance and business and market conditions.
Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
We will not accept unsolicited resumes nor outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees.